Loading viewer...
investor_presentation
Format: PDF investor_presentation
Q2 FY17 investor supplemental presentation containing forward-looking statements on product launches, market strategy, and financial performance. Discusses risks related to network security and storage solutions, competition, and technology development.
investor_presentation
18 Pages
investor_presentation
25 Pages
Western Alliance Bancorporation
investor_presentation
Minerals 260 Limited
Teva Pharmaceutical Industries Investor Presentation — November 2019
investor_presentationinvestor_presentation
38 Pages
Teva Pharmaceutical Industries